Three-Dimensional Conformal Radiotherapy Combined with Gemcitabine and Docetaxel in the Treatment of Advanced Bladder Cancer and Its Effects on Inflammatory Factors and Immune Function

Table 5

Comparison of immune function between the two groups.

Groups		CD3+ (%)				CD4+ (%)				CD4+/CD8+
		Before treatment	After treatment			Before treatment	After treatment			Before treatment	After treatment
Combination group	21			3.041	0.005			4.172	0.003			6.961	<0.001
GT group	21			7.226	<0.001			8.532	<0.001			4.326	0.002
		0.067	0.841			0.075	0.984			0.095	0.856
		0.921	0.312			0.872	0.307			0.752	0.415